76(SUPPL 110):52 Ouellette S, Frias G, Shah R, Alamgir M, Wassef C (2023) Dermal hypersensitivity reaction to semaglutide: two case reports
Incretins and cardiovascular disease: to the heart of type 2 diabetes
Lower incidence of deep vein thrombosis, pulmonary embolism, and pulmonary hypertension, likely due to effects on endothelial function and clotting
Clinical studies, such as the STEP trials, have shown that adults using semaglutide GLP-1 at the recommended dose (2.4 mg weekly) can lose an average of about 15% of their initial body weight over 68 weeks when combined with healthy lifestyle changes
Pills are currently a little cheaper than injections, but the pricing is still evolving
Med J Bakirkoy